MDGS
Get informed when a big investor buys or sells
+ FollowUndervalued by 84.8% based on the discounted cash flow analysis.
| Market cap | $3.85 Million |
|---|---|
| Enterprise Value | $8.18 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-9.5 |
| Beta | 1.37 |
| Outstanding Shares | 1,632,666 |
| P/E Ratio | -0.61 |
|---|---|
| PEG | -0.47 |
| Price to Sales | 0.02 |
| Price to Book Ratio | 0.12 |
| Enterprise Value to Revenue | 0.05 |
| Enterprise Value to EBIT | -0.57 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.67 |
| Debt to Equity | 0.58 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Medigus is a medical device company specializing in developing minimally invasive endosurgical tools and highly innovative imaging solutions across medical and industrial applications.